Larson Financial Group LLC Boosts Holdings in The Cigna Group (NYSE:CI)

Larson Financial Group LLC grew its position in The Cigna Group (NYSE:CI) by 1,183.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,351 shares of the health services provider’s stock after purchasing an additional 3,090 shares during the quarter. Larson Financial Group LLC’s holdings in The Cigna Group were worth $925,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Collier Financial purchased a new position in The Cigna Group during the 4th quarter worth $32,000. ORG Wealth Partners LLC purchased a new stake in shares of The Cigna Group during the fourth quarter worth about $34,000. Prospera Private Wealth LLC acquired a new position in shares of The Cigna Group during the third quarter valued at about $37,000. Compagnie Lombard Odier SCmA purchased a new position in shares of The Cigna Group in the 4th quarter valued at approximately $37,000. Finally, Heck Capital Advisors LLC purchased a new position in shares of The Cigna Group in the 4th quarter valued at approximately $53,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO David Cordani sold 26,527 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares of the company’s stock, valued at $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Nicole S. Jones sold 4,904 shares of the company’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the transaction, the insider now owns 29,421 shares of the company’s stock, valued at approximately $9,065,198.52. This trade represents a 14.29 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by insiders.

The Cigna Group Price Performance

Shares of NYSE CI opened at $321.48 on Monday. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The stock has a market capitalization of $87.98 billion, a price-to-earnings ratio of 26.26, a PEG ratio of 0.98 and a beta of 0.53. The firm’s 50 day simple moving average is $292.84 and its 200-day simple moving average is $317.54. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the business posted $6.79 EPS. Analysts expect that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 1.88%. The ex-dividend date of this dividend is Wednesday, March 5th. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is currently 49.35%.

Analyst Upgrades and Downgrades

CI has been the topic of a number of recent analyst reports. Wells Fargo & Company cut their price target on shares of The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 4th. Stephens dropped their price objective on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Royal Bank of Canada set a $355.00 target price on The Cigna Group in a research note on Friday, January 31st. UBS Group dropped their price target on The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Finally, Sanford C. Bernstein lowered The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price objective on the stock. in a report on Thursday, February 6th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $372.31.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.